Detalhe da pesquisa
1.
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
N Engl J Med
; 388(18): 1657-1667, 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133585
2.
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy.
BMC Cancer
; 23(1): 94, 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707808
3.
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey.
Future Oncol
; 18(29): 3267-3276, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040321
4.
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study.
ESMO Open
; 5(3): e000698, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487542
5.
Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis.
ESMO Open
; 5(4)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817131